These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 7795286)

  • 21. Chronic viral hepatitis: diagnosis and management.
    Maddrey WC
    Hosp Pract (Off Ed); 1994 Feb; 29(2):117-20, 123-6, 129-32. PubMed ID: 8300760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferon alfa-2b in renal transplant recipients with viral chronic hepatitis: a pilot study.
    Monteon FJ; Contreras AM; Espinoza L; Vazquez G; Aguilar S; Cueva L
    Transplant Proc; 1996 Dec; 28(6):3306-8. PubMed ID: 8962284
    [No Abstract]   [Full Text] [Related]  

  • 23. Zidovudine plus interferon alfa-2b treatment in patients with HIV and chronic active viral hepatitis.
    Visco G; Alba L; Grisetti S; Guarascio P; Narciso P; Sette P; Struglia C; Tossini G; Tozzi V
    Gut; 1993; 34(2 Suppl):S107-8. PubMed ID: 8314472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A lethal course of chronic hepatitis C, glomerulonephritis, and pulmonary vasculitis unresponsive to interferon treatment.
    Roithinger FX; Allinger S; Kirchgatterer A; Prischl F; Balon R; Haidenthaler A; Knoflach P
    Am J Gastroenterol; 1995 Jun; 90(6):1006-8. PubMed ID: 7771395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of chronic hepatitis B with interferon alfa-2b (Intron A)].
    Cianciara J; Laskus T; Hryniewicz H; Jabłońska J; Loch T
    Przegl Epidemiol; 1991; 45(4):315-20. PubMed ID: 1841409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A case of primary biliary cirrhosis associated with chronic active hepatitis type C improved by the injection of interferon and the administration of ursodeoxycholic acid].
    Saitoh S; Yamada T; Satoh K; Makita F; Ojima T; Nishijima K; Chishima J; Yamada S; Takagi H; Nagamine T
    Nihon Shokakibyo Gakkai Zasshi; 1993 Sep; 90(9):2152-6. PubMed ID: 8411755
    [No Abstract]   [Full Text] [Related]  

  • 27. [Chronic hepatitis B. Treatment in childhood with alpha-interferon].
    Wirth S; Sokal E; Schaefer E; Pohlenz J; Keller KM
    Monatsschr Kinderheilkd; 1992 Oct; 140(10):775-9. PubMed ID: 1435800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon therapy in hepatitis C--refractory hepatitis--report of the research subgroup of treatment of chronic hepatitis.
    Iino S
    Gastroenterol Jpn; 1993 Mar; 28 Suppl 4():139-42. PubMed ID: 8486225
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of chronic hepatitis C with recombinant interferon alfa.
    Chen YK; Bala K
    West J Med; 1992 Jan; 156(1):72. PubMed ID: 1734608
    [No Abstract]   [Full Text] [Related]  

  • 30. [Re-treatment with interferon-alpha in chronic hepatitis B and C virus infection].
    Teuber G; Dienes HP; Meyer zum Büschenfelde KH; Gerken G
    Z Gastroenterol; 1995 Feb; 33(2):94-8. PubMed ID: 7725763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection from clinical varicella disease during interferon alpha-2a therapy for chronic active hepatitis B infection.
    Curtiss D; Kaufman S; Harrison CJ
    Pediatr Infect Dis J; 1997 Jul; 16(7):720-2. PubMed ID: 9239783
    [No Abstract]   [Full Text] [Related]  

  • 32. MALT non-Hodgkin's lymphoma associated with hepatitis C virus infection treated by interferon alpha.
    Bauduer F
    Am J Hematol; 1996 Nov; 53(3):209. PubMed ID: 8895702
    [No Abstract]   [Full Text] [Related]  

  • 33. Lack of sustained efficacy of interferon in patients with chronic hepatitis C.
    Vento S; Concia E; Ferraro T
    N Engl J Med; 1996 May; 334(22):1479-80. PubMed ID: 8618600
    [No Abstract]   [Full Text] [Related]  

  • 34. [Interferon alpha treatment in chronic hepatitis C].
    Calleri G; Dassio G
    G Batteriol Virol Immunol; 1992 Jan-1993 Dec; 85(1-12):47-54. PubMed ID: 7498616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral erosive lichen planus with epidermolytic hyperkeratosis during interferon alfa-2b therapy for chronic hepatitis C virus infection.
    Schlesinger TE; Camisa C; Gay JD; Bergfeld WF
    J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):1023-5. PubMed ID: 9204077
    [No Abstract]   [Full Text] [Related]  

  • 36. Histological behaviour of chronic hepatitis in patients treated with alpha interferon.
    Villari D; Raimondo G; Freni MA; Rodinò G; Aiello A; Fava A; Longo G; Batolo D
    Pathology; 1992 Oct; 24(4):243-6. PubMed ID: 1289764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Further inquiry into treating hepatitis C with recombinant interferon alpha.
    Puoti C; Fuiano B; Annovazzi G; Pannullo A; Patane F
    Ital J Gastroenterol; 1992 Feb; 24(2):111. PubMed ID: 1576363
    [No Abstract]   [Full Text] [Related]  

  • 38. Therapy of active chronic hepatitis with recombinant alpha 2b-interferon: an 18 month follow-up.
    Bresci G; Parisi G; Banti S; Bertoni M
    Eur J Med; 1993; 2(6):349-52. PubMed ID: 8252180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemolytic anemia secondary to interferon treatment for chronic B hepatitis.
    Fornaciari G; Bassi C; Beltrami M; Castagnetti E; Maccari S; Plancher AC
    J Clin Gastroenterol; 1991 Oct; 13(5):596-7. PubMed ID: 1744407
    [No Abstract]   [Full Text] [Related]  

  • 40. Interferon alpha 2a in patients of chronic hepatitis C.
    Zuberi SJ; Alam SE; Raza S
    J Pak Med Assoc; 1994 Jul; 44(7):171-2. PubMed ID: 7933458
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.